Literature DB >> 10788530

How to improve morbidity and mortality in systemic lupus erythematosus.

M B Urowitz1, D D Gladman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10788530     DOI： 10.1093/rheumatology/39.3.238

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  17 in total

1.  [Systemic lupus erythematosus].

Authors:  C Kneitz; M Goebeler; H P Tony
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

2.  Recurrent Episodes of Myocardial Infarction in a 25-Year-Old Young Man With Systemic Lupus Erythematosus.

Authors:  Stella Pak; Cindy Pham; Bashar Kahaleh
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

Review 3.  Imaging of cardiovascular complications in patients with systemic lupus erythematosus.

Authors:  K Lin; D M Lloyd-Jones; D Li; Y Liu; J Yang; M Markl; J C Carr
Journal:  Lupus       Date:  2015-06-02       Impact factor: 2.911

4.  Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016.

Authors:  Himashi Anver; Shirish Dubey; James Fox
Journal:  Rheumatol Int       Date:  2019-09-30       Impact factor: 2.631

Review 5.  Mortality in Systemic Lupus Erythematosus: an Updated Review.

Authors:  César E Fors Nieves; Peter M Izmirly
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

6.  A pravastatin dose-escalation study in systemic lupus erythematosus.

Authors:  Karen H Costenbader; Matthew H Liang; Lori B Chibnik; Juliet Aizer; Hannah Kwon; Victoria Gall; Elizabeth W Karlson
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

7.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

8.  Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2008-04-02       Impact factor: 2.506

9.  Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.

Authors:  Eiji Suzuki; Eva Karam; Sarah Williams; Dennis K Watson; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2012-09-28       Impact factor: 3.969

10.  Outcomes of rituximab therapy in refractory lupus: A meta-analysis.

Authors:  Fatma Alshaiki; Elaf Obaid; Abdulqader Almuallim; Rabab Taha; Hadeel El-Haddad; Hani Almoallim
Journal:  Eur J Rheumatol       Date:  2018-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.